Home Cart Sign in  
Chemical Structure| 2556836-50-9 Chemical Structure| 2556836-50-9

Structure of DGY-06-116
CAS No.: 2556836-50-9

Chemical Structure| 2556836-50-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DGY-06-116 is an irreversible covalent and selective Src inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DGY-06-116

CAS No. :2556836-50-9
Formula : C32H33ClN8O2
M.W : 597.11
SMILES Code : O=C(C1=CN=C(NC2=CC=C(N3CCN(C)CC3)C=C2)N=C1NC4=CC=CC=C4NC(C=C)=O)NC5=C(C)C=CC=C5Cl
MDL No. :MFCD32899273
InChI Key :HLRQYOGLZWIOPA-UHFFFAOYSA-N
Pubchem ID :154573782

Safety of DGY-06-116

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Related Pathways of DGY-06-116

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MIA PaCa-2R 0.1 μM 24 h To evaluate the synergistic effect of DGY-06-116 with MRTX849, results showed that DGY-06-116 significantly enhanced the growth inhibitory effect of MRTX849 on KRAS-G12C mutant tumor cells. Sci Adv. 2024 Dec 13;10(50):eadq4274
Calu1R 0.1 μM 24 h To evaluate the synergistic effect of DGY-06-116 with MRTX849, results showed that DGY-06-116 significantly enhanced the growth inhibitory effect of MRTX849 on KRAS-G12C mutant tumor cells. Sci Adv. 2024 Dec 13;10(50):eadq4274
SrcC280S kinase mutant 2.6 nM 1 h Evaluate the inhibitory effect of DGY-06-116 on SrcC280S kinase mutant, showing comparable IC50 to wild-type Src, indicating that reversible binding significantly contributes to the potency of this compound Front Mol Biosci. 2020 May 19;7:81
Src kinase 2.6 nM 1 h Evaluate the inhibitory effect of DGY-06-116 on Src kinase activity, showing an IC50 of 2.6 nM, significantly better than SM1-71 and bosutinib Front Mol Biosci. 2020 May 19;7:81

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.67mL

0.33mL

0.17mL

8.37mL

1.67mL

0.84mL

16.75mL

3.35mL

1.67mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories